MARKET

JBIO

JBIO

Jade Biosciences Inc
NASDAQ
16.14
+0.27
+1.70%
After Hours: 15.82 -0.32 -1.98% 18:59 11/13 EST
OPEN
16.28
PREV CLOSE
15.87
HIGH
16.36
LOW
15.58
VOLUME
593.50K
TURNOVER
--
52 WEEK HIGH
28.00
52 WEEK LOW
8.83
MARKET CAP
1.03B
P/E (TTM)
-6.9937
1D
5D
1M
3M
1Y
5Y
1D
Is Jade Biosciences (JBIO) Fully Valued On Book Value Today?
Simply Wall St · 22h ago
Jade Biosciences GAAP EPS of -$0.42
Seeking Alpha · 1d ago
Jade Biosciences Q3 EPS $(0.42) Beats $(0.71) Estimate
Benzinga · 1d ago
*Jade Biosciences 3Q Loss/Shr 42c >JBIO
Dow Jones · 1d ago
*Jade Biosciences 3Q Research and Development Expenses $30.8M >JBIO
Dow Jones · 1d ago
Press Release: Jade Biosciences Reports Third -2-
Dow Jones · 1d ago
Press Release: Jade Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Dow Jones · 1d ago
Jade Biosciences (JBIO) Stock Dropped, So What Is Driving Attention Now?
Simply Wall St · 1d ago
More
About JBIO
Jade Biosciences, Inc. is a biotechnology company, which is focused on developing therapies for autoimmune diseases. The Company’s lead asset, JADE-001, is an investigational anti-A PRoliferation-Inducing Ligand (APRIL) monoclonal antibody for the treatment of Immunoglobulin A (IgA) nephropathy (IgAN), an autoimmune condition in which the kidney is damaged by pathogenic IgA containing immune complexes, leading to proteinuria and kidney function decline, and potentially progressing to end-stage kidney disease requiring dialysis or transplantation. Designed to block the APRIL protein, JADE-001 targets an underlying cause of IgAN, offering the potential to reduce pathogenic IgA levels, decrease proteinuria, and preserve kidney function over the long term. The Company’s pipeline also includes two undisclosed antibody discovery programs: JADE-002 and JADE-003, which are in preclinical development.

Webull offers Jade Biosciences Inc stock information, including NASDAQ: JBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JBIO stock methods without spending real money on the virtual paper trading platform.